The Times Australia
Google AI
The Times News

.

Australia's vaccines boosted with provisional approval for Moderna

  • Written by Michelle Grattan, Professorial Fellow, University of Canberra

The Moderna vaccine has been provisionally approved by the Therapeutic Goods Administration for use in Australia, with one million doses due in the second half of September, which will go to pharmacies.

Three million doses are then scheduled to arrive in each of October, November, and December, with 15 million booster doses in the first half of next year.

Health Minister Greg Hunt said Moderna, an mRNA vaccine, was expected to be available for eligible people from next month, after final advice from the Australian Technical Advisory Group on Immunisation (ATAGI). Moderna has been approved for people 18 and over.

The TGA is also considering Moderna for children, with the head of the TGA Dr John Skerritt saying a decision on its suitability for those 12 and over is expected within the next three to four weeks.

Skerritt said very recently Europe had recommended Moderna’s use for children over 12.

“We made the decision in conjunction with the company to do the adults first because that enabled us to reach a decision earlier, which can then start the whole process of access to the vaccine in Australia earlier. The data on the teenagers does look good,” he said.

Skerritt said even after six months, Moderna was 93% effective against infection, 98% against severe disease and 100% against death. Two doses are required, 28 days apart.

The Moderna announcement came as NSW recorded 283 new locally acquired cases.

Skerritt also said the TGA was working with industry on the wider availability of rapid antigen tests.

“These tests are not the gold standard PCR tests,” he said, but they were a useful adjunct. “Clearly there are a range of things that have to be resolved, such as collection and recording of data.”

The Australian Industry Group’s CEO, Innes Willox, said it was urgent that rapid testing be fully approved as soon as possible.

“Results are very close to lab based tests, almost instantaneous and from the employer’s perspective that means they can be used in some high risk operations at the beginning of a shift or in operations every week or so,” Willox said.

Willox also called on the government “to extend the same indemnity to employers who vaccinate their willing workers at the workplace as is enjoyed by doctors, pharmacists and pharmaceutical companies.

"A medical practitioner who comes to a workplace to give the vaccine would have an indemnity. The employer does not have that same indemnity but should be given it to cover any unexpected circumstances.”

He stressed indemnity had nothing to do with mandating vaccinations.

Morrison, who took another knock in the latest Newspoll [1]in his personal ratings and for his handling of COVID, said the Delta variant has changed everything. “It’s changed all of the rules and it means we’ve had to change with it to keep Australians safe. And, that means, right now, we are going through one of the toughest parts of this COVID pandemic,” he said.

“I know Australians are frustrated. I know they’re sick of it. I know they’re angry. And I know they want it to stop and for life to get back to where they knew it. But, what we have to do now is recognise the reality of the challenge we have in front of us. None of us likes it.”

References

  1. ^ another knock in the latest Newspoll (theconversation.com)

Read more https://theconversation.com/australias-vaccines-boosted-with-provisional-approval-for-moderna-165820

Times Magazine

With Nvidia’s second-best AI chips headed for China, the US shifts priorities from security to trade

This week, US President Donald Trump approved previously banned exports[1] of Nvidia’s powerful ...

Navman MiVue™ True 4K PRO Surround honest review

If you drive a car, you should have a dashcam. Need convincing? All I ask that you do is search fo...

Australia’s supercomputers are falling behind – and it’s hurting our ability to adapt to climate change

As Earth continues to warm, Australia faces some important decisions. For example, where shou...

Australia’s electric vehicle surge — EVs and hybrids hit record levels

Australians are increasingly embracing electric and hybrid cars, with 2025 shaping up as the str...

Tim Ayres on the AI rollout’s looming ‘bumps and glitches’

The federal government released its National AI Strategy[1] this week, confirming it has dropped...

Seven in Ten Australian Workers Say Employers Are Failing to Prepare Them for AI Future

As artificial intelligence (AI) accelerates across industries, a growing number of Australian work...

The Times Features

I’m heading overseas. Do I really need travel vaccines?

Australia is in its busiest month[1] for short-term overseas travel. And there are so many thi...

Mint Payments partners with Zip Co to add flexible payment options for travel merchants

Mint Payments, Australia's leading travel payments specialist, today announced a partnership with ...

When Holiday Small Talk Hurts Inclusion at Work

Dr. Tatiana Andreeva, Associate Professor in Management and Organisational Behaviour, Maynooth U...

Human Rights Day: The Right to Shelter Isn’t Optional

It is World Human Rights Day this week. Across Australia, politicians read declarations and clai...

In awkward timing, government ends energy rebate as it defends Wells’ spendathon

There are two glaring lessons for politicians from the Anika Wells’ entitlements affair. First...

Australia’s Coffee Culture Faces an Afternoon Rethink as New Research Reveals a Surprising Blind Spot

Australia’s celebrated coffee culture may be world‑class in the morning, but new research* sugge...

Reflections invests almost $1 million in Tumut River park to boost regional tourism

Reflections Holidays, the largest adventure holiday park group in New South Wales, has launched ...

Groundbreaking Trial: Fish Oil Slashes Heart Complications in Dialysis Patients

A significant development for patients undergoing dialysis for kidney failure—a group with an except...

Worried after sunscreen recalls? Here’s how to choose a safe one

Most of us know sunscreen is a key way[1] to protect areas of our skin not easily covered by c...